WPI 3720 (Tranexamic acid 650 mg)

Pill imprint WPI 3720 has been identified as Tranexamic acid 650 mg.

Tranexamic acid is used in the treatment of menorrhagia; bleeding disorder; melasma; factor ix deficiency; hemophilia a (and more), and belongs to the drug class miscellaneous coagulation modifiers. There is no proven risk in humans during pregnancy. Tranexamic acid 650 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tranexamic acid

Imprint:

WPI 3720

Strength:

650 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Miscellaneous coagulation modifiers

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.